Charles River, a leading global, end-to-end cell and gene therapy solution provider, is expanding into Bruntwood SciTech’s Alderley Park, in Cheshire. The move will enable the cell and gene therapy development and manufacturing business to increase its High Quality (HQ) plasmid DNA capacity four-fold. The new 17,000 sq ft high-specification lab space at Alderley Park is currently under construction, with the business investing £7m in brand new equipment. Source: BIA News 8/3/22